Clinical Trials Browser

OTHER × Hematologic Neoplasms × Maraviroc × Clear all

NCT01785810 2021-01-11

Phase II Maraviroc for GVHD Prevention

Phase 2 Completed

37 enrolled 17 charts

Other hematologic neoplasm

Hematologic Neoplasms